Literature DB >> 3569760

Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites.

G Daskalopoulos, G Laffi, T Morgan, M Pinzani, H Harley, T Reynolds, R D Zipser.   

Abstract

Furosemide occasionally causes azotemia in patients with ascites, independently of induced volume depletion. To define this effect, we measured renal clearances in patients with chronic liver disease and ascites and in nonascitic controls. Furosemide (80 mg i.v.) transiently increased p-aminohippurate clearance in controls (from 693 +/- 67 to 928 +/- 93 ml/min) and in 11 patients with ascites (from 418 +/- 81 to 526 +/- 80 ml/min). In contrast, in 13 patients with ascites, p-aminohippurate clearance fell by 34% (from 545 +/- 51 to 360 +/- 24 ml/min) within 20 min and by 41% within 60 min, and inulin clearance fell by 19% at 20 min and by 30% at 60 min. The renal effects lasted approximately 4 h. The renal response could not be predicted by renin activity, urinary prostaglandin excretion, urinary sodium, or clinical characteristics. In all 14 patients who received oral furosemide, p-aminohippurate clearance fell within 90 min (by 24%) and remained suppressed for at least 4 h. These immediate effects of furosemide on renal perfusion may contribute to azotemia in some patients with ascites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569760     DOI: 10.1016/0016-5085(87)90616-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

2.  Continuous furosemide infusion in the management of ascites.

Authors:  Nicholas A Rogers; Samir Gupta; Jennifer A Cuthbert
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

3.  Diagnosis and therapy of ascites in liver cirrhosis.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

4.  The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.

Authors:  Nimer Assy; Mohib Kayal; Yoram Mejirisky; Miguel Gorenberg; Osamah Hussein; Sorina Schlesinger
Journal:  BMC Gastroenterol       Date:  2006-11-29       Impact factor: 3.067

5.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Authors:  Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert
Journal:  Wien Klin Wochenschr       Date:  2017-10-23       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.